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Innate lymphoid cells (ILCs) are abundant in mucosal tissues and involved in tissue homeostasis and barrier function. 
Although several ILC subsets have been identified, it is unknown if additional heterogeneity exists, and their differentiation 
pathways remain largely unclear. We applied mass cytometry to analyze ILCs in the human fetal intestine and distinguished 
34 distinct clusters through a t-SNE–based analysis. A lineage (Lin)−CD7+CD127−CD45RO+CD56+ population clustered 
between the CD127+ ILC and natural killer (NK) cell subsets, and expressed diverse levels of Eomes, T-bet, GATA3, and 
RORγt. By visualizing the dynamics of the t-SNE computation, we identified smooth phenotypic transitions from cells 
within the Lin−CD7+CD127−CD45RO+CD56+ cluster to both the NK cells and CD127+ ILCs, revealing potential differentiation 
trajectories. In functional differentiation assays, the Lin−CD7+CD127−CD45RO+CD56+CD8a− cells could develop into CD45RA+ 
NK cells and CD127+RORγt+ ILC3-like cells. Thus, we identified a previously unknown intermediate innate subset that can 
differentiate into ILC3 and NK cells.
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Introduction
Innate lymphoid cells (ILCs) lack expression of T-cell recep-
tors but otherwise are a functional counterpart of cytotoxic 
and T helper (Th) cell subsets. Helper ILCs are classified into 
three groups: ILC1, ILC2, and ILC3 (Spits et al., 2013). ILC1s are 
mainly characterized as lineage (Lin)−CD161+CD127+CRTH2−
CD117−, express the transcription factor T-bet, and produce Th1 
cell–associated cytokines. ILC2s are Lin−CD161+CD127+CRTH2+, 
express GATA3, and produce Th2 cell–associated cytokines. 
ILC3s, including fetal lymphoid tissue–inducer (LTi) cells, are 
Lin−CD161+CD127+CRTH2−CD117+ and RORγt+, and secrete Th17/
Th22 cell–associated cytokines (Spits et al., 2013; Hazenberg and 
Spits, 2014). A fraction of human ILC3s expresses natural cyto-
toxicity receptors such as NKp44, NKp46, and NKp30, and neural 
cell adhesion molecule CD56, similar to natural killer (NK) cells 
(Cella et al., 2009; Cupedo et al., 2009). NK cells are a cytotoxic 
subset of ILCs that express the transcription factor T-bet and/or 
Eomes and produce IFN-γ, granzymes, and perforin (Spits et al., 
2013). Also, ILCs are most abundant and reside in mucosal tissues 
such as the tonsil, lung, and intestine, where they can expand 
locally (Gasteiger et al., 2015).
Several studies have reported the differentiation pathways of 
ILCs in a variety of tissues in both mice and humans (Ishizuka et 
al., 2016b; Juelke and Romagnani, 2016). For example, in mouse 
fetal liver and adult intestine, a CXCR6+RORγt+α4β7+ subset 
has been identified that can differentiate into ILC3s and NK 
cells (Possot et al., 2011). As this subset was not found in adult 
bone marrow, it might migrate to the intestine during fetal 
development. In humans, RORγt+CD34+ progenitor cells were 
identified in the tonsil and intestine, but these were absent in 
peripheral blood, umbilical cord blood, bone marrow, and thy-
mus (Montaldo et al., 2014; Scoville et al., 2016). Because these 
progenitors could differentiate into helper ILCs and NK cells, 
mucosal organs might be the preferential sites for ILC differen-
tiation. In addition, a CD127+CD117+ ILC precursor (ILCP) has been 
identified in cord blood, peripheral blood, and tissues, includ-
ing fetal liver, adult lung, and adult tonsil, that can generate all 
ILC subsets in situ and could represent an intermediate between 
precursor cells and mature ILCs (Lim et al., 2017). Also, previous 
studies have observed ILC plasticity mainly in mucosal tissues, 
such as the small intestine (Bernink et al., 2013, 2015; Bal et al., 
2016; Lim et al., 2016), suggesting that environmental cues may 
play an important role in cell fate decision. So far, most of the 
studies on human ILC differentiation used CD34+ progenitors and 
mature types of ILCs (Juelke and Romagnani, 2016), whereas the 
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intermediates or transitional stages connecting the CD34+ pop-
ulations to mature types of ILCs have not been fully identified.
High-dimensional mass cytometry provides an opportunity to 
analyze the heterogeneity and potential differentiation pathways 
of human ILCs in an unbiased and data-driven fashion based on 
the simultaneous measurement of over 30 cellular markers at 
single-cell resolution (Bandura et al., 2009). Although the sen-
sitivity of metal reporters in mass cytometry is not as sensitive 
as some of the brightest fluorochromes in flow cytometry, the 
advantage of including many more markers in a single antibody 
panel offers unique opportunities to evaluate the composition 
of the immune system with unprecedented resolution. Until 
recently, analysis of flow cytometry data were mainly performed 
with gating strategies based on primarily bimodal expression 
patterns. The incorporation of over 30 markers in mass cytome-
try antibody panels is not well compatible with such an analysis 
approach. Instead, t–distributed stochastic neighbor embedding 
(t-SNE)—based approaches are currently becoming the stan-
dard in the field as they allow the simultaneous analysis of all 
marker expression profiles in an unbiased fashion. Hierarchical 
SNE, for example, allows efficient analysis of mass cytometry 
datasets on tens of millions of cells at the single-cell level (van 
Unen et al., 2017). Here, we applied mass cytometry to analyze 
the ILC compartment in the human fetal intestine and provide 
evidence for previously unrecognized heterogeneity within this 
compartment. Moreover, we used a t-SNE–based computational 
approach to predict potential differentiation trajectories in silico, 
and provide evidence for the existence of a previously unrecog-
nized innate cell subset that can differentiate into both NK cells 
and ILC3 in vitro.
Results
High-dimensional analysis reveals previously unrecognized 
heterogeneity in the ILC compartment
We developed a 35-metal isotope-tagged monoclonal antibody 
panel (Table S1) to identify the six major immune lineages (B cells, 
myeloid cells, CD4+, CD8+, γδ T cells, and Lin−CD7+ cells; the latter 
hereafter referred to as ILCs) and heterogeneity within those lin-
eages. For this purpose, the panel included lineage markers and 
markers linked to cell differentiation, activation, trafficking, and 
responsiveness to humoral factors. With this panel, single-cell 
suspensions prepared from seven fetal intestines were analyzed 
individually. Single, live CD45+ cells were discriminated by event 
length, DNA stainings, and CD45 antibody staining (Fig. S1 A). All 
antibodies showed clear discrimination between antibody-posi-
tive and -negative cells (Fig. S1 B). Similar to our previous study 
(van Unen et al., 2016), we applied a combined t-SNE (van der 
Maaten and Hinton, 2008)–ACC ENSE (Shekhar et al., 2014) data 
analysis approach to the six major cell lineages (Fig. S1 C), which 
revealed a large degree of heterogeneity within these lineages.
We next focused on the ILC compartment (Fig. S2 A), which 
comprised 20.4% ± 7.8% of the CD45+ cells. We pooled the data 
from the seven samples and performed a t-SNE analysis in Cyto-
splore (Höllt et al., 2016). This provided a two-dimensional map 
where cells are positioned based on the similarity in expres-
sion of all markers simultaneously (Fig. 1, A and B). Based on 
the density features of the t-SNE–embedded cells, we identi-
fied 34 phenotypically distinct clusters (Fig. 1, C and D) using 
the Gaussian mean shift clustering and generated a heat map 
showing the distinct marker expression profiles for each clus-
ter (Fig. 1 E). Unbiased hierarchical clustering revealed distinct 
clusters including a group of CD34+ cells expressing CD45RA and 
CD117, a larger cluster of several types of NK cells, and a CD127+ 
ILC cluster with cells expressing markers corresponding to ILC1, 
ILC2, CD45RAhigh ILC3, subsets of several types of CD56+ and 
CD56− ILC3 (Hazenberg and Spits, 2014; Björklund et al., 2016), 
and a CD161− ILC3-like population (Simoni et al., 2017). In addi-
tion, several unrecognized cell clusters with a Lin−CD7+CD127−
CD45RO+CD56+ phenotype (referred to as intermediate ILC [int-
ILC] hereafter) were identified that clustered between the NK 
cells and CD127+ ILCs (Fig. 1, C–E). Although the majority of these 
int-ILCs (6.6% of ILCs ± 2.3%) were CD8a−, a smaller related popu-
lation (3.0% ± 1.6%) was CD8a+ (Fig. 1 F). Importantly, analysis of 
the composition of the cluster frequencies in the individual fetal 
samples demonstrated that even though quantitative differences 
exist, most of the identified clusters, including the int-ILCs, were 
present in all seven samples (Fig. 1 F).
Together, these data indicate that all known NK and CD127+ 
ILC cell clusters could be identified simultaneously, and evi-
dence for the existence of previously unrecognized clusters was 
obtained, as well.
Visualization of the t-SNE computation dynamics predicts 
potential differentiation trajectories in the ILC compartment
The cell surface phenotype of int-ILCs (i.e., CD127−CD45RO+) 
places them in between the CD127+ ILCs and the NK cells (Fig. 1, 
C–E), suggesting potential relationships with both. To investigate 
this in more detail, we sought to visualize potential relation-
ships between cell populations without prior designation of a 
user-defined starting cell type in silico. To this end, we exploited 
the ability of Cytosplore to visualize the evolution of the t-SNE 
map (Höllt et al., 2016). Separating the computational modeling 
into six stages revealed how distinct cell clusters were formed, 
and their high-dimensional similarities were projected onto a 
two-dimensional map and linked to each other based on marker 
expression profiles (Fig. 2 A). Because the initial positions in the 
t-SNE map are assigned randomly, at the first stage of the t-SNE 
computation, all cells were unordered around a single density 
peak. Shortly thereafter, the CD34+ lymphoid precursor cells sep-
arated from the other cells (stage 2), and the first formation of 
the NK and CD127+ ILC clusters became apparent (stages 2 and 
3). These early events were based on relatively large and highly 
discriminatory differences in the expression profiles between 
cell clusters, like the unique combination of CD34 and HLA-DR 
expression by CD34+ cells. At stage 4 of the t-SNE computation, 
the int-ILC cluster was positioned in the center with several dis-
tinct strands of cells forming trajectories toward the NK, CD27+ 
ILC1, KLRG-1+ ILC2, and CD103+ ILC3 clusters. In addition, a tra-
jectory between the ILC2 and ILC3 clusters was visible (stage 4). 
Furthermore, cells from the CD8a− int-ILC population connected 
via the CD8a+ int-ILC population with NK cells, further support-
ing the notion that these two CD8a− and CD8a+ int-ILC popula-
tions are highly related (Fig. 2 A and Fig. S2 B). At the final stage 
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of the t-SNE computation, the 34 clusters were defined, whereas 
the connections between the individual clusters were less clear 
as the t-SNE algorithm eventually assigns cells between two clus-
ters to either one of the two. Individual marker expression pat-
terns at stage 4 of the t-SNE computation gave insight into the 
separations of and the connections between clusters (Fig. 2 B). 
Here, the NK cluster was characterized by the coexpression of 
CD45RA, CD56, CD122, and NKp46, whereas the CD127+ ILC clus-
ter expressed CD45RO, CD117, CD127, CD25 and, to a lesser extent, 
CCR6 and CD103. Similarly, connections between int-ILC to ILC1, 
ILC2, ILC3, and NK cells were marked by gradients of expression 
of CD27, KLRG-1, CD103, and CD56, respectively. The absence of 
CD45RA, CD127, and CCR6 in combination with the presence of 
CD45RO and CD56, and divergent expression of CD117, CD122, and 
CD25, positioned the int-ILC in between the NK cell and ILC clus-
ters. Interestingly, CD56 expression linked the ILC3 to the CD8a− 
int-ILC, and the CD8a+ int-ILC to the NK cells.
We next applied Wanderlust (Bendall et al., 2014) to deter-
mine changes in marker expression along this CD56 continuum 
(Fig.  2  C), which demonstrated that the expression of CD127, 
Figure 1. High-dimensional mass cytometry analysis reveals previously unrecognized heterogeneity in the fetal intestinal ILC compartment. (A) A 
t-SNE embedding showing the collective ILCs (4.5 × 104 cells) derived from seven fetal intestines. Each black dot represents a single cell. (B) A t-SNE embedding 
as shown in A. Colors represent the different samples. (C) A density map describing the local probability density of t-SNE–embedded cells where black dots 
represent centroids of identified clusters using Gaussian mean shift clustering. (D) A t-SNE plot showing cluster partitions in different colors. (E) Heat map 
showing the median ArcSinh5-transformed marker expression values (black-to-yellow scale) of the clusters identified in A with description of 10 annotated 
categories based on preexisting literature, and hierarchical clustering thereof. (F) Composition of the ILC compartment in the individual fetal intestines (n = 7) 
represented in vertical bars where the size of the colored segments represents the proportion of cells as a percentage of total ILC in the sample. Colors as in A.
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CD117, and CD45RO gradually decreased whereas that of CD45RA 
and CD8a increased moving from CD8a− int-ILC to NK cells, via 
CD8a+ int-ILC; and the expression of CD127 and CD117 gradually 
increased from CD8a− int-ILC to ILC3. Altogether, these results 
suggest that these t-SNE–based trajectories may reflect potential 
differentiation pathways.
Expression of cytokines, transcription factors, and CD94 
distinguish int-ILCs from mature CD127+ ILCs and NK cells
To further characterize the int-ILC population, we used the mass 
cytometry data (Fig. S3 A) to design a minimal antibody panel 
to distinguish the CD127−CD45RO+ int-ILCs from CD45RA+ NK 
cells, and to identify the mature CD127+ ILC types through differ-
ential expression of CD117 and CRTH2 (Fig. 3 A). Subsequently, 
we analyzed the proliferative state and examined the capacity of 
the subsets to produce cytokines and express markers linked to 
cytolytic potential by flow cytometry. For the former we stained 
the cells with the proliferation marker Ki-67 ex vivo. The highest 
percentage of Ki-67–positive cells was present in the CD8a+ int-
ILC population (43.9%), whereas a mean of 20% of cells in the 
other subsets were Ki-67–positive (Fig. S3 B). Upon stimulation 
with PMA and ionomycin, perforin/granzyme B was detectable 
in all subsets, but more profoundly in the NK cells and CD8a+ int-
ILCs, compared with the CD8a− int-ILCs and ILC3s (Fig. 3, B and 
C). Moreover, all subsets expressed high levels of TNF-α, whereas 
IFN-γ was detected mainly in the NK cells and CD8a+ int-ILCs but 
hardly in the CD8a− int-ILCs and ILC3s (Fig. 3, B and C). ILC2s 
expressed IL-4, IL-5, and IL-13, but ILC1s, very little IFN-γ (not 
depicted). In contrast, IL-4, IL-5, and IL-13 were undetectable in 
any of the other subsets (not depicted), whereas IL-17A and IL-22 
expression was higher by ILC3s than CD8a− int-ILCs (Fig. 3 D).
Next we determined the expression of key transcription 
factors associated with ILC development and phenotype. The 
expression of ID2, TCF7, AHR, NFIL3, ZBTB16, and TOX did not 
discriminate between the subsets (Fig. S3 C). In line with previ-
ous work (Artis and Spits, 2015), the ILC2 subset was strongly 
GATA3–positive and RORγt–negative, whereas ILC3s were 
GATA3– and RORγt–positive (Fig.  4, A and B; and Fig. S3 D). 
However, we found only low levels of T-bet expression by ILC1 
(Fig. 4, A and B). Notably, both mature NK cells and CD8a+ int-
ILCs expressed high levels of Eomes (Fig. 4, A and B; and Fig. S3, E 
and F). In contrast, the CD8a− int-ILCs were heterogeneous with 
respect to the expression of the four transcription factors, which 
were all expressed by a proportion of the cells (Fig. 4, A and B), 
an expression profile that does not correspond to those found in 
mature CD127+ ILCs. Furthermore, multiple lineage transcription 
factors could be simultaneously expressed by CD8a− int-ILCs, 
such as T-bet and GATA3 (26.1% of CD8a− int-ILCs; Fig. S3, G–I). 
Finally, the frequency of cells expressing Eomes decreased along 
the potential differentiation trajectory linking the NK cells to 
CD8a+ int-ILCs, CD8a− int-ILCs, and ILC3s, whereas that of RORγt 
increased (Fig. 4, A and B).
To investigate the relationship between the int-ILCs, NK cells, 
and ILC3s further, we evaluated the expression of CD62L, CD57, 
CD5, and the NK cell–associated C-type lectin receptor CD94. 
Here, expression of CD62L, CD57, and CD5 was almost lacking and 
did not discriminate between the subsets (not depicted), whereas 
CD94 expression was high on NK cells but virtually absent from 
ILC3s (Fig. 4 C), in agreement with previous studies (Hazenberg 
and Spits, 2014; Scoville et al., 2016). In contrast, only part of the 
int-ILCs were CD94–positive with a higher expression level of 
CD94 on CD8a+ int-ILCs compared with CD8a− int-ILCs (Fig. 4 C), 
a result in line with the lower expression of Eomes in the latter. 
Furthermore, in contrast with CD94− cells, CD94+ cells lacked the 
expression of CD117, similar to mature NK cells (Fig. 4 C).
Together, these data indicate that the int-ILC subset is distinct 
from mature ILCs, where the expression pattern of the cytokines, 
CD94, and transcription factors link the CD8a+ int-ILCs to NK 
cells and the CD8a− int-ILCs to ILC3s.
int-ILC can differentiate into CD45RA+ NK cells
To test the hypothesis that the int-ILC subset may differentiate 
into CD127+ ILCs and/or NK cells, we first purified the CD8a− 
int-ILCs by flow cytometry (Fig. 5 A) and performed functional 
differentiation assays by coculturing these with OP9 stromal 
cells expressing the Notch ligand Delta-like 1 (OP9-DL1). After 
7 d of  culture in medium containing stem cell factor (SCF), 
IL-7, IL-2, and IL-15 (hereafter referred to as NK cytokine mix), 
the majority of the int-ILCs acquired a CD45RA+ phenotype 
(Fig.  5  B) and expanded substantially (Fig.  5  C). Also, these 
cells up-regulated CD94 (42% positive; Fig. S4 A) and displayed 
expression of  Eomes and/or T-bet, but no RORγt or GATA3 
(Fig. 5 D), all similar to mature NK cells. Furthermore, part 
of these cells expressed CD8a (Fig. 5 B), a marker expressed 
by most fetal NK cells ex vivo (Fig.  2  B), where most of  the 
CD8a+ cells displayed the highest expression of Eomes (Fig. 
S4 B). Moreover, a small fraction of  generated cells main-
tained the CD45RA−CD45RO+ int-ILC phenotype, and a frac-
tion of them also acquired CD8a (Fig.  5  B). In line with the 
suggested differentiation trajectory (Fig. 2 C), the expression 
of ILC3-associated RORγt decreased from the CD8a− int-ILCs 
to CD8a+ int-ILCs to CD45RA+ NK cells, whereas all popula-
tions expressed high levels of NK cell–associated Eomes and/
or T-bet (Fig. 5 D). Also, the cells became uniformly Ki-67–pos-
itive (Fig. 5 F), consistent with the observed increase in cell 
numbers (Fig.  5  C). As similar results were obtained when 
Figure 2. Monitoring t-SNE computation dynamics predicts potential differentiation trajectories of ILCs. (A) t-SNE embeddings of the collective ILC sin-
gle-cell data derived from seven fetal intestines showing density features (top) and single cells (bottom) at six stages over the course of the t-SNE computation. 
Colors represent the local probability density of t-SNE–embedded cells (top) or cluster partitions (bottom), as described in Fig. 1 A. (B) t-SNE embeddings at 
stage 4 of the optimization phase as described in A. Colors of the cells represent ArcSinh5-transformed expression values of indicated markers. (C) Left: t-SNE 
embedding at stage 4 as in A. Colors represent density features, and black encirclement indicates the trajectory of cells along the CD56 expression continuum 
shown in B. Right: Wanderlust graph (trajectory 0–1.0) of the CD56-positive cells in the left panel showing median ArcSinh5-transformed expression of CD8a, 
CD45RO, CD45RA, CD7, CD3, CD56, CD117, CD127, and CRTH2 from the CD8a− int-ILCs (shaded red box) via the CD8a+ int-ILC (shaded yellow box) to NK cells 
(shaded blue box), and from the CD8a− int-ILCs to ILC3s (shaded green box). The rainbow color bar indicates relative cell density.
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purified CD8a− int-ILCs were cocultured with OP9 stromal 
cells without Delta-like 1, Notch signaling appears not to be 
involved (Fig. S4 C). In addition, upon culture on OP9-DL1, 
purified CD8a+ int-ILCs also acquired the CD45RA+ NK cell 
phenotype, maintained CD8a expression, and expressed 
high levels of CD94 (84% positive; Fig. S4 D). Finally, purified 
CD8a− int-ILCs cocultured with OP9-DL1 and IL-15 cytokine 
only similarly expanded (not depicted), acquired CD45RA, 
up-regulated CD94 (41% positive), and became in part CD8a–
positive (Fig. S4 E). However, under these conditions, ∼60% of 
these generated cells remained CD117+ (Fig. S4 E), suggesting 
an incomplete conversion to the mature NK–cell phenotype 
(Freud et al., 2006). Together these data indicate that in the 
presence of NK cytokines, proliferative CD45RA+ NK cells are 
generated from int-ILC.
CD8a− int-ILC can differentiate into ILC3
In marked contrast, when purified CD8a− int-ILCs and ILC3s 
(Fig.  5  A) were individually cocultured with OP9-DL1 in cyto-
kine-free culture medium, the ILC3s retained their phenotype, 
whereas the CD8a− int-ILCs acquired an ILC3 phenotype as they 
became CD127+CD117+ (Fig.  5  B), remained CD45RA−CD45RO+ 
(Fig. 5 B), and remained CD8a− (not depicted), in the absence of cell 
expansion and proliferation (Fig. 5, C and G). This phenotype was 
also stable during prolonged culture (Fig. S4 F). In addition, these 
cells homogeneously expressed RORγt, but no Eomes or T-bet 
Figure 3. Cytokine production profiles of fetal intestinal ILCs ex vivo. (A) Representative biaxial plots depicting the gating strategy for ILC1, ILC2, ILC3, 
NK, and int-ILC subsets derived from a human fetal intestine analyzed by flow cytometry. The antibody cocktail contains Lin markers (CD3, CD19, CD11c, and 
CD14), and CD7, CD127, CD56, CRTH2, CD117, CD45RA, CD45RO, and CD8a to allow distinction of the ILC subsets. (B and C) Expression of cytotoxic molecules 
(perforin + granzyme B) and cytokines (IFN-γ and TNF-α) by the indicated subsets defined in A after stimulation with PMA and ionomycin for 6 h. The biaxial 
plots (B) depict one representative experiment, and the bar graphs (C) depict quantification of data obtained from three different human fetal intestines 
(three independent experiments). Error bar shows mean ± SEM. (D) Bar plots depict the secretion of TNF-α, IL-17A, and IL-22 by CD8a− int-ILC and ILC3, after 
stimulation with IL-2, IL-1β, and IL-23 for 4 d, using Luminex bead–based assay of an experiment with three intestines and duplicate wells (two independent 
experiments). Error bar shows mean ± SD. FMO, fluorescence-minus-one control.
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(Fig. 5 E), suggesting an established ILC3 population (Hazenberg 
and Spits, 2014). As similar results were observed when we cocul-
tured the CD8a− int-ILCs with OP9 stromal cells that lacked Notch 
ligand Delta-like 1, Notch signaling appears not to be involved 
(Fig. S4, G and H). Unlike CD8a− int-ILCs and ILC3s, both purified 
CD45RA+ NK cells and CD8a+ int-ILCs did not survive under these 
conditions. To exclude that the generation of ILC3 by int-ILCs was 
a result of outgrowth of contaminating ILC3s, we determined cell 
numbers and the acquisition of CD127 and CD117 at various time 
points during culture. After 24 and 72 h of culture, 38% and 88% 
of purified CD8a− int-ILCs had acquired both CD127 and CD117, 
respectively, whereas no increase in cell numbers was observed 
(Fig. 5, H and I). Together with the observation that only a very 
small proportion of both the purified mature ILC3s and differenti-
ated ILC3s from int-ILCs were Ki-67+ (Fig. 5 G), this indicates that it 
is highly unlikely that selective outgrowth of contaminating ILC3s 
could explain the appearance of cells with an ILC3 phenotype in 
the CD8a− int-ILC/OP9 cocultures. Thus, these results indicate that 
the CD8a− int-ILC population can differentiate into ILC3 in vitro.
Differentiation properties of CD8a− int-ILC subpopulations
By the differential expression of CD94 and CD117, three dis-
tinct CD8a− int-ILC subpopulations could be distinguished: 
CD94+CD117−, CD94−CD117−, and CD94−CD117+ (Fig. 4 C). We there-
fore investigated whether these subsets could differentiate into 
either NK cells or ILC3s in vitro. For this purpose, we first exam-
ined the expression of transcription factors (Fig. 6, A and B). This 
revealed that Eomes was primarily present in the CD94+CD117− 
subset, whereas RORγt expression was most pronounced in the 
CD94−CD117+ subset. In addition, all subsets expressed GATA3 
and T-bet, where T-bet expression was most pronounced by the 
CD117− subsets. Together, these results explain the heterogeneity 
in the expression of transcription factors by CD8a− int-ILCs and 
position the CD94−CD117− subset in between the CD94+CD117− and 
CD94−CD117+ subsets.
Next, we purified CD94+CD117−, CD94−CD117−, and CD94−
CD117+ subsets individually and cocultured them with OP9-DL1 
stromal cells with either NK cytokine mix or cytokine-free 
medium. In the presence of NK cytokine mix (Fig. 6 C), virtually 
Figure 4. Transcription factors and CD94 expression profiles of fetal intestinal ILCs ex vivo. (A and B) Flow cytometric determination of the expression 
of the transcription factors Eomes, T-bet, GATA3, and RORγt by the indicated ILC subsets as defined in Fig. 3 A. Histograms (A) depict the results with one 
representative human fetal intestine, and the graphs (B) depict quantification of data obtained from three different human fetal intestines (three independent 
experiments). Error bar shows mean ± SD. (C) Biaxial plots showing the expression of CD94 and CD117 by the indicated subsets. Results on three human fetal 
intestines are shown (three independent experiments). FMO, fluorescence-minus-one control.
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Figure 5. int-ILC can differentiate into CD45RA+ NK cells and ILC3. (A) Representative histograms depicting the expression of CD127, CD117, CD45RA, 
CD45RO, and CD56 by flow cytometry–purified CD8a− int-ILCs (black line) and ILC3s (gray line) from human fetal intestines. Data are representative of six 
independent experiments. (B–G) Purified CD8a− int-ILCs and ILC3s were cocultured in 96-well plates at 500 cells/well with irradiated OP9-DL1 stromal cells 
for 7 d with culture medium alone or supplemented with NK cytokine mix. Generated cells were analyzed by flow cytometry. Duplicated wells were included 
for each condition. Representative plots show a single duplicate. (B) Representative biaxial plots depict the phenotypes of generated Lin−CD7+ cells based on 
the gating strategy for ILC1, ILC2, ILC3, NK, and int-ILC subsets as shown in Fig. 3 A, for three different combinations of sorted cell populations (int-ILC in black 
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all of the CD94+CD117− cells acquired the CD45RA+ NK cell phe-
notype, maintained expression of high levels of CD94 (76%), 
acquired CD8a expression (43%), and expanded substantially 
(12-fold; not depicted). Similarly, most of the CD94−CD117− cells 
and the majority of the CD94−CD117+ cells also acquired the 
CD45RA+ NK cell phenotype, acquired expression of CD94 (17% 
and 25%, respectively) and CD8a (24% and 16%, respectively), and 
expanded (ninefold and sevenfold, respectively; not depicted). 
In contrast, in cytokine-free medium (Fig. 6 D), both the CD94−
CD117− and CD94−CD117+ int-ILCs acquired an ILC3 phenotype as 
they became CD127+, remained CD45RO+CD45RA−CD94−CD8a−, 
and acquired or increased the levels of CD117 expression, respec-
tively (Fig. 6 D). Similar to CD8a+ int-ILCs and CD45RA+ NK cells, 
the CD94+CD117− int-ILCs did not survive under these conditions.
Collectively, in these in vitro experiments, all three subpop-
ulations of the CD8a− int-ILCs can differentiate into NK cells, 
whereas the CD94−CD117− and CD94−CD117+ cells, but not the 
CD94+CD117− cells, can differentiate into ILC3s.
Discussion
Numerous studies have reported substantial heterogeneity in 
the ILC compartment (Hazenberg and Spits, 2014; Björklund et 
al., 2016). In our mass cytometry–based approach, the NK, ILC1, 
ILC2, and ILC3 subsets could be readily identified in the human 
fetal intestine as well as substantial variability within those 
subsets, results that were highly consistent in several samples 
analyzed. Based on the marker expression profiles, we identi-
fied a large number of distinct NK cell clusters, whose biolog-
ical significance needs to be investigated in the future studies. 
In addition, we found a small CD27+ ILC cluster that matches 
ILC1 criteria (Spits et al., 2013; Klose et al., 2014). However, in 
contrast to findings from Bernink et al. (2013), but in line with 
other studies (Björklund et al., 2016; Simoni et al., 2017), only a 
few of these ILC1s expressed T-bet. Furthermore, two additional 
CD127+ ILC1-like clusters were identified that clustered with the 
NK cells because of the expression of several NK cell–associated 
markers, including CD45RA, CD56, CD8a, and NKp46. Consistent 
with previous studies (Hazenberg and Spits, 2014; Bernink et al., 
2015; Björklund et al., 2016), the ILC3 compartment was most 
frequent and heterogeneous, including CD45RO+ ILC3, CD45RA+ 
ILC3, HLA-DR+ ILC3, and CD56+/− ILC3 clusters. Further studies 
will be required to clarify the potential functional significance 
of observed heterogeneity in the ILC3 lineage. We could not dis-
tinguish LTi cells from ILC3s as no specific cell surface marker 
for human LTi cells was available at the time we performed our 
analysis. Moreover, although most of the human ILCs described 
express CD161 (Spits et al., 2013; Hazenberg and Spits, 2014), we 
also detected a recently described CD161−CD117+ ILC3-like cluster 
that clustered with the CD127+ ILCs (Simoni et al., 2017). In addi-
tion, we identified two previously unknown CD8a+ counterparts 
of ILC3s that warrant further investigation. We also observed a 
rare CD34+CD45RA+CD117+ population that resembles the CD34+ 
precursors recently described in human tonsils and intestines 
after birth (Montaldo et al., 2014; Scoville et al., 2016).
Finally, we identified a Lin−CD7+CD127−CD45RO+CD56+ group 
of cells that by unbiased clustering was positioned between the 
CD45RA+ NK cells and CD127+ ILCs, and was termed int-ILC. 
Although in previous studies (Spits et al., 2013; Hazenberg and 
Spits, 2014) such CD56+CD127− cells were classified as NK cells, 
the simultaneous use of CD45RA and CD45RO allowed us to dis-
tinguish these CD45RO+ cells from the CD45RA+ NK cells. It is 
important to note that these int-ILCs display variable expression 
of several surface markers, including CD8a, CD94, CD117, CD122, 
CD25, CD27, KLRG-1, and CD103, indicating that they are not a 
homogenous group of cells. Their unique position between the 
NK cells and CD127+ ILCs, however, prompted us to investigate 
potential relationships between these cell clusters.
In recent years, several studies have explored developmen-
tal pathways by applying computational approaches on mass 
cytometry datasets. Wanderlust accurately predicted B–cell 
lymphopoiesis (Bendall et al., 2014), and Wishbone was found 
to recover the T–cell developmental pathway (Setty et al., 2016) 
at single-cell resolution. However, Wanderlust is not suitable to 
predict multilineage differentiation trajectories. Although Wish-
bone can be used to identify bifurcating developmental trajec-
tories, it needs the designation of a user-defined precursor cell 
type. As we wished to investigate potential developmental rela-
tionships without preassumptions, we developed a novel com-
putational approach to visualize the evolution of the t-SNE map 
over the course of the optimization. t-SNE is a nonlinear dimen-
sionality reduction algorithm that projects the high-dimensional 
similarities onto a two-dimensional map based on the concurrent 
marker expression profiles (van der Maaten and Hinton, 2008). 
Here t-SNE not only employs bimodal distribution patterns but 
also incorporates gradients of the expression of cellular markers 
and therefore offers superior resolution. Importantly, the Cyto-
splore framework (Höllt et al., 2016) can visualize every iteration 
by making use of the A-tSNE (Pezzotti et al., 2017). This allowed 
us to analyze potential relationships between the int-ILC, ILC1, 
ILC2, ILC3, and NK clusters through visualization of gradients 
along putative differentiation trajectories. Such gradients are 
contours, ILC3 in gray contours) and culture conditions as indicated (three to five independent experiments). (C) Quantification of the generated Lin−CD7+ cells 
in B in absolute cell number (left axis) and fold change (right axis) compared with the number of initially sorted cells (dashed line; two to four independent 
experiments). Error bar shows mean ± SD. (D and E) Histograms depict the expression of transcription factors Eomes, T-bet, GATA3, and RORγt by the indicated 
subsets generated from sorted CD8a− int-ILCs with NK cytokine mix and (D) sorted CD8a− int-ILCs or ILC3s with culture medium (E). Numbers indicate the 
percentage of positive cells. Combined data on five human fetal intestines. (F and G) Biaxial plots depict the expression of Ki-67 by indicated subsets gener-
ated from the combinations of sorted cell populations (int-ILC in black contours, ILC3 in gray contours) and culture conditions as in D and E. Combined data 
on five human fetal intestines. (H and I) Purified CD8a− int-ILCs were cocultured at 500 cells/well with irradiated OP9-DL1 stromal cells in culture medium 
and harvested at the time points indicated in hours. Duplicated wells were included in each experiment (two independent experiments). (H) Quantification of 
the generated Lin−CD7+ cells in absolute cell number (left axis) and fold change (right axis) compared with the number of initially sorted cells (dashed line). (I) 
Representative biaxial plots show the expression of CD127 and CD117 by the generated Lin−CD7+ cells. FMO, fluorescence-minus-one control.
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Figure 6. Distinct differentiation properties of CD8a− int-ILC subpopulations. (A and B) Expression of the transcription factors Eomes, T-bet, GATA3, and 
RORγt by the indicated subpopulations of CD8a− int-ILC ex vivo. Histograms depict the results with one fetal intestine (A), and the graphs depict quantification 
of data obtained from three intestines (B; two independent experiments). Error bar shows mean ± SD. (C and D) Purified CD94+CD117−CD8a− int-ILC, CD94−
CD117−CD8a− int-ILC, and CD94−CD117+CD8a− int-ILC populations were cocultured in 96-well plates at 500 cells/well with irradiated OP9-DL1 stromal cells for 
7 d with (C) culture medium supplemented with NK cytokine mix or (D) culture medium alone. Generated cells were analyzed by flow cytometry. Representative 
biaxial plots depict the phenotypes of the generated Lin−CD7+ cells based on the gating strategy for ILC1, ILC2, ILC3, NK, and int-ILC subsets as shown in Fig. 3 A, 
for the five combinations of cell populations and culture conditions indicated. Duplicated wells were included in each condition. Representative plots show a 
single duplicate (three to four independent experiments).
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clearly visible in our Cytosplore analysis (Fig. 2) and contribute 
to the generation of cell clusters. Our current results indicate 
that at least some of those gradual changes in marker expres-
sion profiles correlate with differentiation pathways of immune 
subsets. Consistent with the observed plasticity among ILCs 
(Bernink et al., 2015; Bal et al., 2016), the analysis revealed a clear 
trajectory between the ILC2 and ILC3 clusters. This may imply 
that the CD103− ILC2 can differentiate into CD103+ ILC3 locally 
depending on physiological or pathological conditions. Alterna-
tively, the fetal ILC2s may leave the intestine, in line with pre-
vious studies concluding that ILC2s can be found in the periph-
eral blood (Mjösberg et al., 2011) but are virtually absent in the 
human intestine after birth (Bernink et al., 2015). In addition, 
a trajectory within the CD56+ cell compartment was revealed, 
where the CD8a- int-ILC was connected with the CD56+ ILC3 
on one side and with the CD8a+ int-ILC and the NK cells on the 
other. Importantly, although the above analysis was performed 
on the innate cell population present in the seven fetal intestines 
collectively, similar relationships between cell populations were 
revealed when the innate cell compartment of each fetal sam-
ple was analyzed individually, attesting to the robustness of the 
approach (Fig. S2 B).
The putative link between the int-ILC and the mature ILC and 
NK cells is further strengthened by several other observations. 
First, both the cytokine production profiles and the CD94 expres-
sion profile ex vivo link the CD8a+ int-ILCs to NK cells and the 
CD8a− int-ILCs to the ILC3s. Second, the expression pattern of 
the transcription factors by int-ILCs is heterogeneous with fea-
tures of both NK cells (Eomes and T-bet) and ILC3s (GATA3 and 
RORγt), where the CD8a+ int-ILCs resemble the NK cells whereas 
the CD8a− int-ILCs are closer to CD127+ ILCs. Finally, in the OP9-
based coculture system, in the presence of NK cytokines, puri-
fied int-ILC expanded and displayed a CD45RA+Eomes+/T-bet+ 
NK–cell phenotype, whereas in the absence of cytokines, the 
cells did not expand but acquired a stable CD127+CD117+RORγt+ 
ILC3 phenotype.
Further dissection of the CD8a− int-ILC compartment demon-
strated the existence of three distinct subpopulations based on 
differential expression of CD94 and CD117: CD94+CD117−, CD94−
CD117−, and CD94−CD117+. In our in vitro experiments, both the 
Eomes-expressing CD94+CD117− and non–Eomes-expressing 
CD94−CD117− and CD94−CD117+ subpopulations could differen-
tiate into CD45RA+ NK cells when cultured with NK cytokine 
mix. Furthermore, the differentiation into CD45RA+ NK cells 
was most efficient in the case of the CD94+CD117− cells and least 
for the CD94−CD117+ cells, compatible with a model where the 
CD94+CD117− cells are positioned close to NK cells, the CD94−
CD117+ cells most distant, and the CD94−CD117− cells in between. 
The acquisition of CD8a by the CD94−CD8a− int-ILCs in these cul-
tures indicates that the CD8a+ int-ILC may also be an intermedi-
ate stage toward NK–cell differentiation. In the absence of cyto-
kines, CD117+CD127+ ILC3-like cells could be generated from both 
CD94−CD117+ and CD94−CD117− cells but not from CD94+CD117− 
cells. Together this indicates that CD94+CD117− cells can exclu-
sively differentiate into NK cells whereas the other two popula-
tions can differentiate into both NK cells and ILC3s, at least under 
the in vitro conditions used.
In the absence of cytokines, the int-ILC changed into ILC3-like 
cells without signs of cell expansion, cell division, or cell death, 
arguing that the generation of ILC3 from the int-ILC is not a result 
of selective outgrowth of contaminating ILC3s. In agreement, we 
did not observe any proliferative response of flow cytometry–
purified ILC3 under the same experimental conditions.
In mice, it has been shown that developmental hierarchy 
of ILCs goes from the common lymphoid progenitor to mature 
ILCs via α4β7-expressing lymphoid progenitor, early innate 
lymphoid progenitor, common helper ILC progenitor, and the 
ILCP (Ishizuka et al., 2016b). Here early innate lymphoid pro-
genitor has been distinguished from other progenitors by the 
lack of CD127 and ILC lineage-specific transcription factors 
(Yang et al., 2015), whereas the ILCP exhibits coexpression 
of transcription factors associated with ILC1, ILC2, and ILC3 
subsets (Ishizuka et al., 2016a). Finally, a mouse fetal transi-
tional CD127+ ILCP has been identified in the intestine which 
expresses varying amount of T-bet, GATA3, and RORγt (Bando 
et al., 2015). In humans, two studies have shown that ILC3s 
can be generated from RORγt+CD34+ progenitors from tonsils 
and intestines (Montaldo et al., 2014; Scoville et al., 2016), but 
little is known about the intermediate stages. Interestingly, 
Scoville et al. (2016) generated both NK cells and the three 
types of helper ILCs from these CD34+ progenitors in vitro; 
however, the generated cells did not express CD127 but rather 
CD161 and intracellular ILC-related cytokine profiles. Also, an 
NK cell lineage–restricted CD34+ progenitor was identified in 
the human fetal liver and bone marrow (Renoux et al., 2015). 
In contrast, CD127− int-ILCs in our study express CD45RO and 
variable levels of Eomes, T-bet, GATA3, and RORγt, but no CD34 
and CD45RA, markers expressed by most human progenitors. 
Also, with our mass cytometry approach, we have been unable 
to identify cells with an int-ILC phenotype in the human fetal 
liver and fetal spleen (not depicted), indicating that the int-ILC 
may specifically reside in mucosal tissues. Together, the cell 
surface phenotype, tissue distribution, and transcription factor 
profiles of CD127− int-ILC suggest that these cells are distinct 
from previously identified ILC progenitors and may be in an 
intermediate differentiation stage among ILC lineages. Finally, 
we observed that the ILC3s and NK cells derived from the CD8a− 
int-ILC could partly revert their phenotype upon prolonged cul-
ture, indicating that the int-ILC may represent an intermediate 
between two plastic lineages (not depicted).
It has been shown that environmental cues including OP9/
OP9-DL1 stromal cells and cytokines such as IL-7 and SCF play an 
important role in driving ILC3 differentiation (Satoh-Takayama 
et al., 2010; Montaldo et al., 2014; Scoville et al., 2016). Although 
the addition of SCF and IL-7 did promote significant expansion 
of the CD8a− int-ILCs, they did not differentiate into other types 
of cells (not depicted). Instead, the differentiation of CD8a− int-
ILCs toward ILC3s occurred in cytokine-free medium. In mice, 
Notch signaling for ILC3 development is necessary in adults but 
not in fetuses (Possot et al., 2011), whereas in humans, the differ-
entiation of CD34+ progenitors to ILC3s can occur without Notch 
signaling (Montaldo et al., 2014; Scoville et al., 2016). Consistent 
with these observations, the generation of ILC3s from the CD8a− 
int-ILCs was Notch-independent.
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In conclusion, we delineated the heterogeneity of ILCs in 
the human fetal intestine and developed a computational model 
to predict potential differentiation trajectories based on mass 
cytometry data. This allowed the identification of a previously 
unidentified innate cell cluster that harbors cells that can dif-
ferentiate into NK cells and ILC3-like cells in vitro. This may 
provide plasticity in the human fetal intestine in response to 
external stimuli.
Materials and methods
Human fetal intestine and cell isolation
Human fetal intestines from elective abortions were collected 
after informed consent. Approval by the medical ethical commis-
sion of the Leiden University Medical Center (protocol P08.087) 
was obtained in accordance with the local ethical guidelines and 
the Declaration of Helsinki. The gestational age ranged from 
16 to 22 wk. Single-cell suspensions from fetal intestines were 
prepared as previously described. In brief, the mesentery, colon 
part, and meconium were removed from the fetal intestine. The 
intestines were then cut into small fragments and treated with 
1 mM 1,4-dithiothreitol (Fluka) in 15 ml of HBSS (Sigma-Aldrich) 
for 2 × 10 min (replacing buffer) at room temperature (rT) to dis-
solve the mucus and subsequently with 1 mM EDTA (Merck) in 
15 ml of HBSS under rotation for 2 × 1 h (replacing buffer) at 37°C 
to separate the epithelium from the lamina propria fraction. To 
obtain single-cell suspensions from the lamina propria, the intes-
tines were rinsed with HBSS and incubated with 15 ml IMDM 
(Lonza) supplemented with 10% FCS, 10 U/ml collagenase IV 
(Worthington), and 200 µg/ml DNase I grade II (Roche Diagnos-
tics), at 37°C overnight, after which cell suspensions were filtered 
through a 70-µm nylon cell strainer. Finally, the immune cells 
were isolated with a Percoll (GE Healthcare) gradient and stored 
in liquid nitrogen.
Mass cytometry antibody staining and data acquisition
Details on antibodies used are listed in Table S1. Conjugation 
of the purified antibodies with metal reporters was performed 
with the MaxPar X8 antibody labeling kit (Fluidigm Sciences) 
according to the manufacturer's instructions. Procedures for 
mass cytometry antibody staining and data acquisition were per-
formed as previously described (van Unen et al., 2016). In brief, 
cells from fetal intestinal lamina propria were thawed and incu-
bated with 1 ml 500× diluted 500 µM Cell-ID intercalator-103Rh 
(Fluidigm Sciences) for 15 min at rT to identify dead cells. Cells 
were then stained with metal-conjugated antibodies for 45 min 
at rT. After staining, cells were labeled with 1 ml 1,000× diluted 
125 µM Cell-ID intercalator-Ir (Fluidigm Sciences) to stain all cells 
in MaxPar Fix and Perm Buffer (Fluidigm Sciences) overnight 
at 4°C. Finally, cells were acquired by CyTOF 2 mass cytometer 
(Fluidigm Sciences). Data were normalized by using EQ Four Ele-
ment Calibration Beads (Fluidigm Sciences) with the reference 
EQ passport P13H2302 during the course of each experiment.
Mass cytometry data analysis
The biaxial plots showing antibody staining patterns in Fig. S1 
were generated in Cytobank (Kotecha et al., 2010). Data for single, 
live CD45+ cells gated from each fetal intestine individually using 
Cytobank (Kotecha et al., 2010) as shown in Fig. S1 A were sam-
ple-tagged and hyperbolic arcsinh–transformed with a cofactor 
of 5 before t-SNE analysis. The 907 clusters shown in Fig. S1 C 
were identified by analyzing the entire immune system (CD45+ 
cells) using the t-SNE–ACC ENSE analysis pipeline as described 
before (van Unen et al., 2016). Next, t-SNE was performed for 
the ILC dataset using A-tSNE (Pezzotti et al., 2017) in Cytosplore 
(Höllt et al., 2016). t-SNE was performed with default parame-
ters (perplexity, 30; iterations, 1,000). All t-SNE plots were gen-
erated in Cytosplore. Hierarchical clustering of the heat map was 
created with Pearson Correlation and mean linkage clustering 
in MultiExperiment Viewer (http:// www .tm4 .org). Wanderlust 
analysis was performed on cells that were selected along the lin-
ear CD56 expression continuum at stage 4 of the t-SNE compu-
tation with the CD56+CD8a+ ILC3 cluster as starting point (as this 
cluster is located at the outer end of the CD56 trajectory), using 
Cyt in Matlab (Bendall et al., 2014).
Antibodies and flow cytometry
FITC-conjugated anti-CD11c (3.9), PerCP-Cy5.5–conjugated 
anti-CD45RO (UCHL1), PE/Dazzle 594–conjugated anti-CD45RA 
(HI100), PE-Cy7–conjugated anti-CD127 (A019D5), Brilliant 
Violet 605–conjugated anti-CRTH2 (BM16), anti–T-bet (4B10), 
PE-conjugated anti–T-bet (4B10), anti–IFN-γ (4S.B3), anti–IL-5 
(TRFK5), anti–IL-13 (JES10-5A2), anti–IL-17A (BL168), and anti–
TNF-α (Mab11) were purchased from BioLegend. The following 
monoclonal antibodies were purchased from BD: FITC-con-
jugated anti-CD3 (SK7), anti-CD19 (4G7), anti-CD14 (MϕP9), 
APC-conjugated anti-CD117 (YB5.B8), APC-R700–conjugated 
anti-CD56 (NCAM16.2), V450-conjugated anti-CD7 (M-T701), 
Brilliant Violet 605–conjugated anti-CD94 (HP-3D9), PE-con-
jugated anti-CD94 (HP-3D9), anti-RORγt (Q21-559), anti–Ki-67 
(B56), anti-perforin (δG9), and anti–IL-4 (3010.211). PE-conju-
gated anti-Eomes (WD1928), anti-GATA3 (TWAJ), anti–granzyme 
B (GB11), and eFluor 660–conjugated anti-GATA3 (TWAJ) were 
purchased from eBioscience. PE-conjugated anti–IL-22 (IC7821P) 
was purchased from R&D Systems. Pacific Orange–conjugated 
anti-CD8a (3B5) was purchased from Life Technologies.
For the cell surface staining, cells were incubated with fluoro-
chrome-conjugated antibodies and human FC block (BioLegend) 
for 30–45 min at 4°C. The transcription factor staining was per-
formed by using Foxp3 Staining Buffer Set (eBioscience) accord-
ing to the manufacturer’s instructions. For the intracellular cyto-
kine staining/cytotoxic molecule, cells were stimulated with 0.1 
mg/ml PMA (Sigma-Aldrich) and 1 µg/ml ionomycin (Sigma-Al-
drich) for 6 h at 37°C, and GolgiPlug (BD Biosciences) was added 
for the final 4 h, after which cells were stained by using Fixation 
Buffer and Intracellular Staining Perm Wash Buffer (BioLegend). 
Cells were acquired on an LSR II cytometer (BD Biosciences) or 
sorted on a FAC SAria III sorter (BD Biosciences) based on the 
gating strategy as shown in Fig. 3 A. Data were analyzed with 
FlowJo V10 software.
Quantitative real-time PCR
RNA extraction was performed with the NucleoSpin RNA XS kit 
(Macherey-Nagel). cDNA was synthesized with the High Capacity 
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cDNA Reverse Transcription kit (Applied Biosystems). Real-time 
PCR was performed in a StepOnePlus Real-Time PCR Systems 
(Applied Biosystems) with FastStart Universal SYBR Green Mas-
ter Mix (Roche). ΔCt values were calculated using GAP DH as 
reference gene. The sequences of real-time PCR primers are as 
follows: GAP DH, forward primer: 5′-GTC TCC TCT GAC TTC AAC 
AGCG-3′; reverse primer: 5′-ACC ACC CTG TTG CTG TAG CCAA-3′; 
AHR, forward primer: 5′-CTT AGG CTC AGC GTC AGT TA-3′; reverse 
primer: 5′-GTA AGT TCA GGC CTT CTC TG-3′; ID2, forward primer: 
5′-TTG TCA GCC TGC ATC ACC AGAG-3′; reverse primer: 5′-AGC CAC 
ACA GTG CTT TGC TGTC-3′; NFIL3, forward primer: 5′-TGG AGA 
AGA CGA GCA ACA GGTC-3′; reverse primer: 5′-CTT GTG TGG CAA 
GGC AGA GGAA-3′; ZBTB16, forward primer: 5′-GAG CTT CCT GAT 
AAC GAG GCTG-3′; reverse primer: 5′-AGC CGC AAA CTA TCC AGG 
AACC-3′; TOX, forward primer: 5′-AGC ATA CAG AGC CAG CCT 
TG-3′; reverse primer: 5′-TGC ATG GCA GTT AGG TGA GG-3′; and 
TCF1, forward primer: 5′-TGC AGC TAT ACC CAG GCT GG-3′; reverse 
primer: 5′-CCT CGA CCG CCT CTT CTTC-3′.
Cell culture and differentiation assays
OP9-DL1 or OP9 stromal cells were maintained in Minimum 
Essential Medium α (Lonza) supplemented with 10% FCS. Flow 
cytometry–purified CD8a− int-ILCs or CD94+CD117−, CD94−
CD117−, and CD94−CD117+ subpopulations (500 cells/well) or 
CD8a+ int-ILCs (100 cells/well) were cocultured with irradi-
ated OP9 or OP9-DL1 stromal cells (1,500 rad, 5,000 cells/well) 
in a 96-well plate (Corning) and maintained in culture medium 
(IMDM supplemented with 10% human serum) or in culture 
medium containing 25 ng/ml SCF (Miltenyi Biotec), 25 ng/ml IL-7 
(Peprotech), 10 U/ml IL-2 (Novartis), and 10 ng/ml IL-15 (R&D 
Systems) or only IL-15. The phenotype of generated progeny was 
determined by flow cytometry.
Cytokine secretion
CD8a− int-ILCs and ILC3 (2,000 cells/well) were stimulated 
with 10 U/ml IL-2 (Novartis), 50 ng/ml IL-1β (Peprotech), 
and 50 ng/ml IL-23 (Peprotech) for 4 d. TNF-α, IL-17A, and 
IL-22 were measured by using Bio-Plex Pro human cytokine 
17-plex panel kit and Bio-Plex Pro human Treg cytokine panel 
12-plex kit (Bio-Rad).
Online supplemental material
Fig. S1 shows the mass cytometry–based analysis of the entire 
immune system in the human fetal intestine. Fig. S2 shows 
t-SNE–based analysis of the Lin−CD7+ innate immune com-
partment in the human fetal intestine. Fig. S3 shows Ki-67 and 
transcription factor expression profiles of fetal intestinal ILCs 
ex vivo. Fig. S4 is related to Fig. 5, and shows that CD8a− int-ILC 
can differentiate into CD45RA+ NK cells and ILC3. Table S1 lists 
the information of antibodies used in the mass cytometry data.
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